High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

Clinical trial NCT06646211 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06646211
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma (PCNSL)Non Hodgkin Lymphoma (NHL)

Start date: 2025-01-01
Primary completion: 2028-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.